πŸ‡ΊπŸ‡Έ FDA
Patent

US 11344559

PI3KGAMMA inhibitors

granted A61KA61K31/4196A61K31/438

Quick answer

US patent 11344559 (PI3KGAMMA inhibitors) held by The Regents of the University of California expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/4196, A61K31/438, A61K31/444, A61K31/453